Tibetan Medicine

Conflict of interests The authors declare no conflict of interest. References 1, , , , , , Int. J. Mol. Sci. 2019, 20 (14), 154–163. https://doi.org/10/gg6dxt. 2, , , Planta Med. 1987, 53 (5), 410–414. https://doi.org/10.1055/s-2006-962759. 3, , , , , , Trop. J. Pharm. Res. 2017, 16 (5), 1121–1129. https://doi.org/10.4314/tjpr.v16i5.22. 4, , , , , , , , , , , , , , Int. J. Biol. Macromol. 2016, 92, 116–124. https://doi.org/10/f88nrc. 5, , , , , , Afr. J. Tradit. Complementary Altern. Med. 2013, 10 (5), 380–385.

Corresponding Author Hengchang Zang NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China Key Laboratory of Chemical Biology (Ministry of Education), Shandong University, Jinan, Shandong, China National Glycoengineering Research Center, Shandong University, Jinan, Shandong, China Correspondence Hengchang Zang, NMPA Key Laboratory for Technology Research and...

The results of the double index sequence analysis. Basic grouping was employed in the M1–M18 sequence. According to the common peak rate, the most comparable sample pairs and groups could be sorted into the Tables 5–8. The common peak rate and variation peak rate of the sequence were the same in group A, and the absorption peak corresponded completely. The sequence common peak rate was high in group B, whereas its variation peak rate was low.